Current Grants


Current Grants Awarded to Faculty

  • Shanjana Awasthi, Ph.D.

    Title of Project: "Surfactant protein-A regions as TLR4-immunomodulators"

    • Sponsoring Agency: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
    • Time Period: 08/08/17 through 07/31/22

  • Vibhudutta Awasthi, Ph.D.

    Title of Project: "Immunokinetics of superhydrophili polymer-modified liposome encapsulated hemoglobin"

    • Sponsoring Agency: Oklahoma Center for the Advancement of Science and Technology (OCAST)
    • Time Period: 09/01/17 through 08/31/20

    Title of Project: "Pharmacotherapy of traumatic brain injury accompanied by hemorrhagic shock.""

    • Sponsoring Agency: Department of Defense (DoD)
    • Time Period: 09/30/17 through 09/29/20

  • Hibah Awwad, Ph.D.

    Title of Project: "Histamine release in traumatic brain injury: Neurotoxic or neuroprotective?"

    • Sponsoring Agency: American Association of Colleges of Pharmacy (AACP)
    • Time Period: 01/01/17 through 12/31/17

  • Randle Gallucci, Ph.D.

    Title of Project: "The role of IL-6 receptor in irritant dermatitis."

    • Sponsoring Agency: National Institute of Occupational Safety and Health/NIH Center for Disease Control
    • Time Period: 09/01/13 through 08/31/18

  • Michael Ihnat, Ph.D.

    Title of Project: "Role of IL-6 and Stat3 in triple-negative breast cancer (TNBC) metastatic progression."

    • Sponsoring Agency: Presbyterian Health Foundation
    • Time Period: 01/11/17 through 01/10/18

  • Anne Kasus-Jacobi, Ph.D.

    Title of Project: "Wound healing mechanisms modulated by novel antimicrobial peptides."

    • Sponsoring Agency: Oklahoma Center for the Advancement of Science and Technology (OCAST)
    • Time Period: 08/01/15 through 07/31/18

    Title of Project: "Antibacterial activity of CAP37 peptides."

    • Sponsoring Agency: Biolytx Corporation
    • Time Period: 02/02/16 through 12/31/17

  • Shellie Keast, Ph.D., Pharm.D.

    Title of Project: "Prescription opioid performance improvement metrics and heroin abuse"

    • Sponsoring Agency: Oregon State University/Centers for Disease Control and Prevention (CDC)
    • Time Period: 09/01/16 through 08/31/18

    Title of Project: "DUR Foster Care collaboration development project for the State of Oklahoma"

    • Sponsoring Agency: Oklahoma Health Care Authority (OHCA)
    • Time Period: 07/01/16 through 09/30/17

    Title of Project: "Drug utilization review board (DUR)"

    • Sponsoring Agency: Oklahoma Health Care Authority (OHCA)
    • Time Period: 07/01/17 through 06/30/18

    Title of Project: "Research Fellowship Agreement"

    • Sponsoring Agency: Purdue Pharma
    • Time Period: 08/01/16 through 07/31/18

    Title of Project: "SMINET - Applying evidence to improve care and outcomes in severe mental illness."

    • Sponsoring Agency: Rutgers University
    • Time Period: 07/01/16 through 06/30/18

  • William M. McShan, Ph.D.

    Title of Project: "Phage-like chromosomal islands and virulence in pneumococci"

    • Sponsoring Agency: NIH Center of Biomedical Research Excellence (CoBRE)/Oklahoma State University (OSU); Oklahoma Center for Respiratory and Infectious Diseases (OCRID)
    • Time Period: 07/01/17 through 06/30/18

  • H. Anne Pereira, Ph.D.

    Title of Project: "50th annual meeting of the Society for Leukocyte Biology (SLB)"

    • Sponsoring Agency: National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID)
    • Time Period: 06/20/17 through 05/31/18

  • R. Chris Rathbun, Pharm.D.

    Title of Project: "HIV Drug Assistance Program (HDAP) to promote adherence."

    • Sponsoring Agency: Oklahoma State Department of Health
    • Time Period: 04/01/11 through 03/31/2018

  • Scott E. Schaeffer, D.Ph., DABAT

    Title of Project: "Acute poisoning management and educational activities for Oklahoma"

    • Sponsoring Agency: Oklahoma Department of Human Services (ODHS)
    • Time Period: 07/01/17 through 06/30/18

  • Kelly Standifer, Ph.D.

    Title of Project: "Post-traumatic stress disorder and co-morbid chronic pain: Evidence that TNF initiates a sequelae involving nocioceptin/orphanin FQ"

    • Sponsoring Agency: Oklahoma Center for the Advancement of Science and Technology (OCAST)
    • Time Period: 08/01/17 through 07/31/20

  • Sukyung Woo, Ph.D.

    Title of Project: "Overcoming resistance to Anti-VEGT therapy with predictive modeling."

    • Sponsoring Agency: American Cancer Society (ACS)
    • Time Period: 07/01/16 through 06/30/20

  • Youngjae You, Ph.D.

    Title of Project: "A synergistic combination therapy of photodynamic therapy and chemotherapy for breast cancer"

    • Sponsoring Agency: Department of Defense (Idea Expansion)
    • Time Period: 09/19/14 through 09/18/18

    Title of Project: "Visible light-controlled combination strategy for treating nonmuscle invasive bladder cancers"

    • Sponsoring Agency: Department of Defense (DoD)
    • Time Period: 08/01/17 through 07/31/19

    Title of Project: "Photo-unclick chemistry and its application to near infrared-activatable prodrugs"

    • Sponsoring Agency: National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS)
    • Time Period: 01/31/16 through 01/31/20

    Title of Project: "NIR-activatable prodrugs for treating peritoneally metastasized ovarian cancers"

    • Sponsoring Agency: National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
    • Time Period: 03/01/15 through 01/31/20

  • Wei Yue, Ph.D.

    Title of Project: "Function and regulation of OATP1B3"

    • Sponsoring Agency: National Institute of Health/National Institute of General Medical Sciences (NIH/NIGMS)
    • Time Period: 09/01/11 through 08/31/18

    Title of Project: "AFPE Pre-doctoral fellowship for Alex Crow"

    • Sponsoring Agency: American Foundation for Pharmaceutical Education (AFPE)
    • Time Period: 09/01/17 through 08/31/18